Literature DB >> 23970414

Senescence at a glance.

Jeff S Pawlikowski1, Peter D Adams, David M Nelson.   

Abstract

Cellular senescence is a stable proliferation arrest that is associated with extensive cellular remodelling and an altered secretory pathway. Through its numerous inducers that lead to altered gene expression, senescence is able to influence many contrasting functions and pathologies, namely tumour suppression, tumour promotion, wound healing and ageing. As senescence is able to control such important tissue functions, it is now being pinpointed as a possible route for novel therapies. This article and accompanying poster aim to provide a summary of the initiators, pathways and roles of senescence, as well as present examples of senescence and a possible use for senescence in therapy.

Entities:  

Mesh:

Year:  2013        PMID: 23970414      PMCID: PMC3772382          DOI: 10.1242/jcs.109728

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  93 in total

Review 1.  Is cellular senescence an example of antagonistic pleiotropy?

Authors:  Stefano Giaimo; Fabrizio d'Adda di Fagagna
Journal:  Aging Cell       Date:  2012-03-15       Impact factor: 9.304

2.  Enumeration of the simian virus 40 early region elements necessary for human cell transformation.

Authors:  William C Hahn; Scott K Dessain; Mary W Brooks; Jessie E King; Brian Elenbaas; David M Sabatini; James A DeCaprio; Robert A Weinberg
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

4.  Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

Authors:  Tae-Won Kang; Tetyana Yevsa; Norman Woller; Lisa Hoenicke; Torsten Wuestefeld; Daniel Dauch; Anja Hohmeyer; Marcus Gereke; Ramona Rudalska; Anna Potapova; Marcus Iken; Mihael Vucur; Siegfried Weiss; Mathias Heikenwalder; Sadaf Khan; Jesus Gil; Dunja Bruder; Michael Manns; Peter Schirmacher; Frank Tacke; Michael Ott; Tom Luedde; Thomas Longerich; Stefan Kubicka; Lars Zender
Journal:  Nature       Date:  2011-11-09       Impact factor: 49.962

5.  A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.

Authors:  Masashi Narita; Masako Narita; Valery Krizhanovsky; Sabrina Nuñez; Agustin Chicas; Stephen A Hearn; Michael P Myers; Scott W Lowe
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

6.  Telomerase reverse transcriptase delays aging in cancer-resistant mice.

Authors:  Antonia Tomás-Loba; Ignacio Flores; Pablo J Fernández-Marcos; María L Cayuela; Antonio Maraver; Agueda Tejera; Consuelo Borrás; Ander Matheu; Peter Klatt; Juana M Flores; José Viña; Manuel Serrano; Maria A Blasco
Journal:  Cell       Date:  2008-11-14       Impact factor: 41.582

Review 7.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 8.  Telomerase and cancer therapeutics.

Authors:  Calvin B Harley
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

9.  Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence.

Authors:  Graeme Hewitt; Diana Jurk; Francisco D M Marques; Clara Correia-Melo; Timothy Hardy; Agata Gackowska; Rhys Anderson; Morgan Taschuk; Jelena Mann; João F Passos
Journal:  Nat Commun       Date:  2012-02-28       Impact factor: 14.919

10.  Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions.

Authors:  Anitha Suram; Jessica Kaplunov; Priyanka L Patel; Haihe Ruan; Aurora Cerutti; Virginia Boccardi; Marzia Fumagalli; Raffaella Di Micco; Neena Mirani; Resham Lal Gurung; Manoor Prakash Hande; Fabrizio d'Adda di Fagagna; Utz Herbig
Journal:  EMBO J       Date:  2012-05-08       Impact factor: 11.598

View more
  17 in total

Review 1.  Growth hormone in the tumor microenvironment.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Arch Endocrinol Metab       Date:  2019 Nov-Dec       Impact factor: 2.309

2.  Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis.

Authors:  Ying-Ying Liu; Yao Shi; Ya Liu; Xing-Hua Pan; Ke-Xiong Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-06-20       Impact factor: 6.150

3.  GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment.

Authors:  Rindert Missiaen; Nicole M Anderson; Laura C Kim; Bailey Nance; Michelle Burrows; Nicolas Skuli; Madeleine Carens; Romain Riscal; An Steensels; Fuming Li; M Celeste Simon
Journal:  Cell Metab       Date:  2022-07-14       Impact factor: 31.373

4.  Characterization of Induction and Targeting of Senescent Mesenchymal Stromal Cells.

Authors:  Robert C H Gresham; Devanshi Kumar; Jonathan Copp; Mark A Lee; J Kent Leach
Journal:  Tissue Eng Part C Methods       Date:  2022-06       Impact factor: 3.273

5.  Combined therapies that induce senescence and stabilize p53 block melanoma growth and prompt antitumor immune responses.

Authors:  Anna Vilgelm; Ann Richmond
Journal:  Oncoimmunology       Date:  2015-03-19       Impact factor: 8.110

Review 6.  Aneuploidy as a promoter and suppressor of malignant growth.

Authors:  Anand Vasudevan; Klaske M Schukken; Erin L Sausville; Vishruth Girish; Oluwadamilare A Adebambo; Jason M Sheltzer
Journal:  Nat Rev Cancer       Date:  2021-01-11       Impact factor: 69.800

7.  Meeting Report: International Symposium on the Genetics of Aging and Life History II.

Authors:  Murat Artan; Ara B Hwang; Seung V Lee; Hong Gil Nam
Journal:  Aging (Albany NY)       Date:  2015-06       Impact factor: 5.682

8.  Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks.

Authors:  Alan E Bilsland; Angelo Pugliese; Yu Liu; John Revie; Sharon Burns; Carol McCormick; Claire J Cairney; Justin Bower; Martin Drysdale; Masashi Narita; Mahito Sadaie; W Nicol Keith
Journal:  Neoplasia       Date:  2015-09       Impact factor: 5.715

Review 9.  Long noncoding RNAs(lncRNAs) and the molecular hallmarks of aging.

Authors:  Ioannis Grammatikakis; Amaresh C Panda; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Aging (Albany NY)       Date:  2014-12       Impact factor: 5.682

10.  Impaired ATP6V0A2 expression contributes to Golgi dispersion and glycosylation changes in senescent cells.

Authors:  Miyako Udono; Kaoru Fujii; Gakuro Harada; Yumi Tsuzuki; Keishi Kadooka; Pingbo Zhang; Hiroshi Fujii; Maho Amano; Shin-Ichiro Nishimura; Kosuke Tashiro; Satoru Kuhara; Yoshinori Katakura
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.